subscribeSubscribe
GSK to cap out-of-pocket inhaler costs in US

GSK to cap out-of-pocket inhaler costs in US
REUTERS
21 Mar 2024
Share Share
Drugmakers benefit `substantially` from secondary patents on inhalers — study

Drugmakers benefit `substantially` from secondary patents on inhalers — study
Nicole DeFeudis ENDPTS
03 Jan 2023
Share Share
Enforcement Report- Week of October 27, 2021

Enforcement Report- Week of October 27, 2021
FDA
27 Oct 2021
Share Share
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler®

Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler®
BLOOMBERG
21 Sep 2020
Share Share
Cipla submits application with USFDA for generic version of asthma drug

Cipla submits application with USFDA for generic version of asthma drug
ECONOMICTIMES
18 May 2020
Share Share
Cipla share price up 8% on successful completion of Ph-3 study of asthma drug

Cipla share price up 8% on successful completion of Ph-3 study of asthma drug
MONEYCONTROL
02 Apr 2020
Share Share
Teva announces FDA approval of ArmonAir Digihaler inhalation powder

Teva announces FDA approval of ArmonAir Digihaler inhalation powder
Anthony Vecchione NJBIZ
24 Feb 2020
Share Share
GSK leans on respiratory franchise with Trelegy share-grab

GSK leans on respiratory franchise with Trelegy share-grab
Beth Snyder Bulik FIERCE PHARMA
30 Oct 2019
Share Share
FDA knocks back AstraZeneca`s respiratory ambitions

FDA knocks back AstraZeneca`s respiratory ambitions
J.Gardner BIOPHARMADIVE
02 Oct 2019
Share Share
Charging at blockbuster Advair, Novartis boasts topline victories

Charging at blockbuster Advair, Novartis boasts topline victories
Amber Tong ENDPTS
30 Sep 2019
Share Share